Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03037021 · ClinicalTrials.gov registry record

Improving Sickle Cell Disease (SCD) Care Using Web-based Guidelines

A clinical trial, sponsored by Duke University.

Completed
Registry status
213
Enrollment target

NCT03037021 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 213 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03037021 has completed, sponsored by Duke University.

COMPLETED
Registry status
213 participants
Enrollment target

Study Summary

The overall goal of this proposed project is to 1) increase co-management between sickle cell specialists and primary care providers (PCP's); 2) increase the use of hydroxyurea (HU) which prevents Vaso-Occlusive Episode (VOE), EDs and subsequent hospitalizations, and death; 3) identify and link patients not receiving primary or SCD specialty care to care, and 4) shift healthcare use from EDs and hospitalizations to primary and specialty co-management. Many persons with SCD experience a poor quality of life, serious medical complications and frequent painful events that require treatment from SCD specialty care, primary care and emergency department (ED) providers. There are two dominating models of care in the United States; neither are ideal. Many people with SCD have all of their healthcare needs addressed by sickle cell specialists who do not typically provide primary care and are often geographically distant from the patients' home. Other sickle cell patients receive all of their care in EDs. Both models are inadequate and result in an alarmingly high number of ED visits for many patients. Current care models are neither cost efficient nor promoting optimal patient outcomes. To improve outcomes, the investigators will implement a new model of care for SCD using nurse care managers, web based-interactive algorithms, and test if additional patient provided coaching can improve outcomes.

Trial Details

FieldValue
Enrollment Target 213 participants
Start Date 2017-05-31
Est. Completion 2017-12-07

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03037021

The ClinicalTrials.gov registry entry for NCT03037021 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03037021 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03037021 about?

NCT03037021 is a clinical study titled "Improving Sickle Cell Disease (SCD) Care Using Web-based Guidelines". The overall goal of this proposed project is to 1) increase co-management between sickle cell specialists and primary care providers (PCP's); 2) increase the use of hydroxyurea (HU) which prevents Vaso-Occlusive Episode (VOE), EDs and subsequent hospitalizations, and death; 3) identify and link pati...

What is the current status of trial NCT03037021?

This trial is currently completed. The enrollment target is 213 participants. The study started on 2017-05-31. Estimated completion is 2017-12-07.

Who is sponsoring clinical trial NCT03037021?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.